IMMUNIC, INC. — Director's Dealing 2014

Nov 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-11-17

Reporting Person: DUNN JOHN MICHAEL (General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-17	Stock Option (right to buy)	$19.03	A	50000	Acquired	2024-11-16	Common Stock (50000)	Direct

Footnotes

F1: One forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly from the vesting commencement date, on the same day of the month as the vesting commencement date, such that all of the shares of common stock subject to the option are vested by the fourth anniversary of the vesting commencement date, subject to the reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")) through each vesting date; provided, that, 100% of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).